AC Immune SA

General ticker "ACIU" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $313.4M (TTM average)

AC Immune SA follows the US Stock Market performance with the rate: 6.3%.

Estimated limits based on current volatility of 2.4%: low 1.57$, high 1.65$

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [1.82$, 3.79$]
  • 2025-12-31 to 2026-12-31 estimated range: [1.46$, 3.12$]

Financial Metrics affecting the ACIU estimates:

  • Negative: Non-GAAP EPS, $ of -0.59 <= 0.04
  • Positive: 43.26 < Shareholder equity ratio, % of 48.62 <= 63.75
  • Positive: Operating cash flow per share per price, % of 21.99 > 12.73
  • Negative: negative Operating income
  • Positive: -3.20 < Investing cash flow per share, $ of -1.06
  • Negative: negative Net income

Similar symbols

Short-term ACIU quotes

2025-03-142025-03-172025-03-182025-03-192025-03-202025-03-212025-03-242025-03-252025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-251.41.61.822.22.4
Price $

Long-term ACIU plot with estimates

1.522.533.544.55Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 2027−0.2−0.10
ACIUS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue CHF3.94MM CHF14.80MM CHF27.31MM
Operating Expenses CHF74.78MM CHF68.42MM CHF79.69MM
Operating Income CHF-70.85MM CHF-53.62MM CHF-52.38MM
Non-Operating Income CHF0.11MM CHF-0.60MM CHF1.47MM
Interest Expense CHF0.35MM CHF0.18MM CHF0.13MM
R&D Expense CHF60.34MM CHF54.61MM CHF62.57MM
Income(Loss) CHF-70.74MM CHF-54.22MM CHF-50.91MM
Taxes CHF0.01MM CHF0.01MM CHF0.00MM
Profit(Loss)* CHF-70.75MM CHF-54.23MM CHF-50.92MM
Stockholders Equity CHF168.99MM CHF160.64MM CHF112.27MM
Inventory CHF0.00MM CHF0.00MM CHF0.00MM
Assets CHF185.94MM CHF182.81MM CHF230.91MM
Operating Cash Flow CHF-73.57MM CHF-60.41MM CHF65.84MM
Capital expenditure CHF1.24MM CHF0.80MM CHF0.58MM
Investing Cash Flow CHF23.76MM CHF65.64MM CHF-105.29MM
Financing Cash Flow CHF-1.35MM CHF43.25MM CHF-1.12MM
Earnings Per Share** CHF-0.85 CHF-0.64 CHF-0.46

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.